Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

A flow cytometry-based assay for quantifying non-plaque forming strains of yellow fever virus.

Hammarlund E, Amanna IJ, Dubois ME, Barron A, Engelmann F, Messaoudi I, Slifka MK.

PLoS One. 2012;7(9):e41707. doi: 10.1371/journal.pone.0041707. Epub 2012 Sep 19.

2.

Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.

Trindade GF, Marchevsky RS, Fillipis AM, Nogueira RM, Bonaldo MC, Acero PC, Caride E, Freire MS, Galler R.

An Acad Bras Cienc. 2008 Jun;80(2):311-21.

3.
4.

Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

Pincus S, Mason PW, Konishi E, Fonseca BA, Shope RE, Rice CM, Paoletti E.

Virology. 1992 Mar;187(1):290-7.

PMID:
1736531
5.

Comparison of neurovirulence of different strains of yellow fever virus in mice.

Barrett AD, Gould EA.

J Gen Virol. 1986 Apr;67 ( Pt 4):631-7.

PMID:
3958694
6.

New approaches for the standardization and validation of a real-time qPCR assay using TaqMan probes for quantification of yellow fever virus on clinical samples with high quality parameters.

Fernandes-Monteiro AG, Trindade GF, Yamamura AM, Moreira OC, de Paula VS, Duarte AC, Britto C, Lima SM.

Hum Vaccin Immunother. 2015;11(7):1865-71. doi: 10.4161/21645515.2014.990854.

7.

Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.

Engelmann F, Josset L, Girke T, Park B, Barron A, Dewane J, Hammarlund E, Lewis A, Axthelm MK, Slifka MK, Messaoudi I.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3295. doi: 10.1371/journal.pntd.0003295. eCollection 2014.

8.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.

Vaccine. 1999 Apr 9;17(15-16):1869-82.

PMID:
10217584
9.

Engineered resistance in Aedes aegypti to a West African and a South American strain of yellow fever virus.

Higgs S, Rayner JO, Olson KE, Davis BS, Beaty BJ, Blair CD.

Am J Trop Med Hyg. 1998 May;58(5):663-70.

PMID:
9598458
10.
11.

[Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].

Ergünay K, Saygan MB, Aydoğan S, Litzba N, Niedrig M, Pınar A, Us D.

Mikrobiyol Bul. 2010 Jul;44(3):415-24. Turkish.

PMID:
21063991
12.

First international external quality assessment study on molecular and serological methods for yellow fever diagnosis.

Domingo C, Escadafal C, Rumer L, Méndez JA, García P, Sall AA, Teichmann A, Donoso-Mantke O, Niedrig M.

PLoS One. 2012;7(5):e36291. doi: 10.1371/journal.pone.0036291. Epub 2012 May 3.

13.

In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).

Ono L, Wollinger W, Rocco IM, Coimbra TL, Gorin PA, Sierakowski MR.

Antiviral Res. 2003 Nov;60(3):201-8.

PMID:
14638396
15.

A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.

Thibodeaux BA, Garbino NC, Liss NM, Piper J, Schlesinger JJ, Blair CD, Roehrig JT.

Antiviral Res. 2012 Apr;94(1):1-8. doi: 10.1016/j.antiviral.2012.02.001. Epub 2012 Feb 15.

16.

Characterization of the antigen distribution and tissue tropisms of three phenotypically distinct yellow fever virus variants in orally infected Aedes aegypti mosquitoes.

McElroy KL, Girard YA, McGee CE, Tsetsarkin KA, Vanlandingham DL, Higgs S.

Vector Borne Zoonotic Dis. 2008 Oct;8(5):675-87. doi: 10.1089/vbz.2007.0269.

PMID:
18494601
17.

Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes.

McElroy KL, Tsetsarkin KA, Vanlandingham DL, Higgs S.

J Gen Virol. 2005 Jun;86(Pt 6):1747-51.

PMID:
15914853
18.

Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus.

Barrett AD, Mathews JH, Miller BR, Medlen AR, Ledger TN, Roehrig JT.

J Gen Virol. 1990 Jan;71 ( Pt 1):13-8.

PMID:
1689367
19.

Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.

Freire MS, Mann GF, Marchevsky RS, Yamamura AM, Almeida LF, Jabor AV, Malachias JM, Coutinho ES, Galler R.

Vaccine. 2005 Mar 31;23(19):2501-12.

PMID:
15752837
20.

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.

Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP.

J Virol. 2004 Sep;78(18):9998-10008.

Supplemental Content

Support Center